Avior Wealth Management LLC Cuts Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Avior Wealth Management LLC trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 36.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,244 shares of the pharmacy operator’s stock after selling 1,893 shares during the quarter. Avior Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $85,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. Dark Forest Capital Management LP boosted its holdings in Walgreens Boots Alliance by 6.5% during the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after acquiring an additional 1,804 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Walgreens Boots Alliance by 36.2% during the 3rd quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock worth $48,269,000 after purchasing an additional 576,534 shares during the period. Van ECK Associates Corp raised its stake in shares of Walgreens Boots Alliance by 28.2% during the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock worth $2,873,000 after purchasing an additional 28,400 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of Walgreens Boots Alliance by 3.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator’s stock worth $32,130,000 after purchasing an additional 47,071 shares during the period. Finally, Vanguard Group Inc. raised its stake in shares of Walgreens Boots Alliance by 14.5% during the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. In other Walgreens Boots Alliance news, Director Valerie B. Jarrett acquired 4,456 shares of the business’s stock in a transaction dated Monday, January 29th. The stock was bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares of the company’s stock, valued at $99,992.64. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction dated Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders have purchased a total of 13,456 shares of company stock worth $270,423 over the last ninety days. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Stock Up 3.7 %

Shares of WBA opened at $18.24 on Friday. The business’s 50-day moving average price is $20.42 and its 200-day moving average price is $21.92. Walgreens Boots Alliance, Inc. has a twelve month low of $17.51 and a twelve month high of $36.14. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. During the same period in the prior year, the business posted $1.16 earnings per share. The company’s revenue was up 6.3% on a year-over-year basis. On average, analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday, April 3rd. HSBC reiterated a “reduce” rating and set a $20.00 target price (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. UBS Group lowered their target price on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Truist Financial reiterated a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Finally, Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.